Loading...

FERMENTA Fermenta Biotech Ltd Quarterly Earnings Reports Announcement

Frmn

FRMN

Fermenta Biotech Ltd

(FERMENTA)

2024 Announcement

Trading admission

Regulatory Compliance

Trading window closure

Regulatory Announcement

Analyst / Investor Meeting

Investor Presentation

Unaudited results publication

Earnings Release

Board Meeting Outcome

Unaudited results

Board Meeting Intimation

Regulatory Compliance

Regulatory compliance

Insider Trading Restrictions

Employee Recognition

Analyst / Investor Meet

Fundraising through securities

Funding through securities ...

Capacity expansion at Dahej...

Board meeting to consider f...

Investor Meetings

Investor Presentation

Newspaper Publication

H1 FY26 results

Unaudited Results

Unaudited results

Board Meeting Notice

Regulatory Compliance

Investment Update

Credit Rating Upgrade

IEPF Campaign Announcement

Directorate Change

Great Place Certification

Business Sale Announcement

Sale of Environment Business

Share Transfer Notice

Earnings Presentation

Financial Results Publication

Q1FY26 Financials

73rd AGM Presentation

CEP Grant Announcement

Newspaper Publication

Annual General Meeting

Regulatory Compliance

Strategic MoU Signed

Investor Meeting

Investor Presentation

Dividend Record Date

Financial Results Published

Compliance Report

Financial Results FY25

ESOP & Appointments

Wholly-Owned Subsidiary

75th Anniversary

SEBI Compliance Certificate

Show Cause Notice

New Subsidiary Planned

Postal Ballot Notice

Director Reappointment

Share Acquisition

Award Recognition

Credit Rating Revised

Investor Meeting

Investor Presentation

Financial Results Publication

Insider Trading Update

Sale Deeds Execution

Compliance Certificate

Name Change Announcement

Director Changes

Investor Meeting

Postal Ballot Notice

Investor Meeting

Earnings Presentation Q2

Financial Results Published

Compliance Certificate

Asset Sale Agreement

EU GMP Certification

EU GMP Compliance

Earnings Presentation

Financial Results

Newspaper Publication

Investor Presentation

Management Change

Newspaper Publication

Newspaper Advertisement

Dematerialization Certificate

Successful Inspection Closure

Earnings Presentation Corre...

Earnings Presentation

Record Date Clarification

Compliance Report Submission

Management Change

Financial Results Publication

Management Change

Newspaper Publication

Retirement Announcement

Board Meeting Outcome

Compliance Certificate

Compliance Certificate Subm...

Certificates Certification

Retirement of Directors

Credit Rating Change

Retirement of Directors

Appointment of Chairman

Earnings Presentation

Newspaper Publication

Sale of Premises

Financial Results Publication

Appointment and Approval

Certificate under Reg. 74 (...

Loss of Share Certificates

Duplicate Share Certificate

Sale Deed Execution

Earnings Presentation

Earnings Presentation Intim...

Credit Rating Revision

Loss Of Share Certificates

Publication of Financial Re...

Publication of Unaudited Fi...

Certificate under Reg. 74 (...

Investor Presentation

Inauguration of Premix Plant

Newspaper Advertisement For...

Earnings Presentation

Financial Statements

Shareholders Agreement

Natural disaster - heavy ra...

Natural disasters

Merger of Equals

Earnings Presentation

Financial Statements Public...

Compliance Filing

Merger of Equals

Management Changes

Merger of Equals

External Links:

Data:

Fermenta Biotech Ltd announced the release of its earnings presentation for Q2 FY 2024-25, highlighting its global operations in over 60 countries and its position as a leading manufacturer of Vitamin D3, with over 350 clients worldwide.

AI Assistant

Fermenta Biotech Ltd

2024

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.